This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Michael Kessler: Innovator in Skin Cancer Treatment
Introduction
Michael Kessler is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of medical science, particularly in the treatment of skin cancer. His innovative approach has the potential to improve the lives of many individuals at risk of this disease.
Latest Patents
Kessler holds a patent for "Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists." This patent outlines methods for treating subjects who have skin cancer or are at risk of developing it. Additionally, it provides techniques for identifying individuals with an increased risk of developing skin cancer. He has 1 patent to his name, showcasing his commitment to advancing medical treatments.
Career Highlights
Michael Kessler is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its innovative therapies. His work at Regeneron has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to medical science.
Collaborations
Kessler has worked alongside talented colleagues such as Eric Jorgenson and Aris I Baras. These collaborations have fostered an environment of innovation and creativity, leading to advancements in the treatment of skin cancer.
Conclusion
Michael Kessler's work in developing methods for treating skin cancer exemplifies the impact of innovation in healthcare. His contributions are paving the way for better treatment options and improved patient outcomes.